GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (MEX:OGN) » Definitions » Other Long Term Assets

Organon (MEX:OGN) Other Long Term Assets : MXN28,078 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Organon Other Long Term Assets?

Organon's other long-term assets for the quarter that ended in Sep. 2024 was MXN28,078 Mil.

Organon's quarterly other long-term assets increased from Mar. 2024 (MXN19,816 Mil) to Jun. 2024 (MXN21,911 Mil) and increased from Jun. 2024 (MXN21,911 Mil) to Sep. 2024 (MXN28,078 Mil).

Organon's annual other long-term assets increased from Dec. 2021 (MXN14,237 Mil) to Dec. 2022 (MXN14,700 Mil) and increased from Dec. 2022 (MXN14,700 Mil) to Dec. 2023 (MXN20,895 Mil).

Organon Other Long Term Assets Historical Data

The historical data trend for Organon's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Other Long Term Assets Chart

Organon Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial 13,975.26 8,991.18 14,236.72 14,699.98 20,895.30

Organon Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,228.07 20,895.30 19,815.93 21,910.84 28,078.37

Organon Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Organon Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (MEX:OGN) » Definitions » Other Long Term Assets
Comparable Companies
AMRN SCLX MIRA LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD LSE:GSK TSE:4568 TSE:4519 XTER:BAYN SHSE:600276
Traded in Other Exchanges
OGN:USA 1OGN:Italy 7XP:Germany
Address
30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Website
https://www.organon.com
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.